You are here: Industry Insights > ADHD

News List

Stimulant Treatment Has Strong Protective Effect in ADHD drugs
July 30, 2019
For youth with attention-deficit/hyperactivity disorder (ADHD), stimulants have strong protective effects on functional outcomes...
Athletes With ADHD May Need More Time to Recover From Concussion: Study drugs
July 29, 2019
College athletes with attention- deficit hyperactivity disorder (ADHD) may be slower to recover from a concussion and may have more severe symptoms.
Pediatricians Can Play Role in Ensuring School Readiness drugs
July 23, 2019
Social-emotional and behavioral skills are important for school readiness, and preschoolers with...
Recovery From Concussion Longer for Athletes With ADHD drugs
July 19, 2019
Recovery From Concussion Longer for Athletes With ADHD.
FDA permits marketing of first non-drug treatment for ADHD pharmatimes
April 24, 2019
The US Food and Drug Administration (FDA) has permitted marketing for the Monarch external Trigeminal Nerve Stimulation (eTNS) System, a new medical device to treat attention deficit hyperactivity disorder (ADHD).
FDA permits marketing of first medical device for treatment of ADHD worldpharmanews
April 24, 2019
The U.S. Food and Drug Administration (FDA) permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD).
FOQUEST Receives Approval for Expanded Indication for Children and Adolescents with ADHD firstwordpharma
March 13, 2019
Today's news is an exciting development for young Canadians and their families who now have a new option to help manage their ADHD," said Purdue Pharma (Canada) President and CEO David Pidduck.
App may work 'like Ritalin' on brain to focus ADHD sufferers firstwordpharma
January 21, 2019
Cambridge University scientists will launch a free app on Monday that they claim works like "digital Ritalin" to improve focus, reported The Sydney Morning Herald.
Risk Up for Later-Born Siblings of Children With ASD, ADHD drugs
December 11, 2018
Later-born siblings of children with autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD) have an elevated risk of being ....
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals pharmafocusasia
December 03, 2018
Tris Pharma, Inc. (Tris), a pharmaceutical company focused on developing innovative technology-based therapeutic products that address unmet patient needs....

Previous page 1 2 3 4 5 6 Next page